Tonita Wroolie

Publications

• Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease. Kenna H, Hoeft F, Kelley R, Wroolie T, DeMuth B, Reiss A, Rasgon N. Neurobiol Aging. 2013; 34 (3): 641-9
• Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens. Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Khaylis A, Rasgon NL. Am J Geriatr Psychiatry. 2011; 19 (9): 792-802
• Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, Williams KE, Powers BN, Hallmayer J, Reiss A. Neurobiol Aging. 2011; 32 (11): 1942-8
• Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. Rasgon NL, Kenna HA, Williams KE, Powers B, Wroolie T, Schatzberg AF. ScientificWorldJournal. 2010: 10 321-8
• Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study. Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Lazzeroni L, Rasgon NL. Acta Neurol Scand. 2009; 119 (3): 172-9
• Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study. Rasgon NL, Dunkin J, Fairbanks L, Altshuler LL, Troung C, Elman S, Wroolie TE, Brunhuber MV, Rapkin A. J Psychiatr Res. 2007 Apr-Jun; 41 (3-4): 338-43
• Mood and neuropsychological changes in women with midlife depression treated with escitalopram. Wroolie TE, Williams KE, Keller J, Zappert LN, Shelton SD, Kenna HA, Reynolds MF, Rasgon NL. J Clin Psychopharmacol. 2006; 26 (4): 361-6